- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04344314
Impact of PIVC Length and Gauge on Catheter Indwell Time
A Randomized Controlled Post-market Study to Assess the Impact of Peripheral Intravenous Catheter Length and Gauge on Catheter Indwell Duration and Haemolysis in Human Participants Using a Bilateral, Cephalic Vein Cannulation Model
This is a single-centre, open-label, multi-visit study design, in 40 healthy participants, randomized by gauge of peripheral intravenous catheter (PIVC) device into the lower arm cephalic vein of both arms.
The purpose of this study is to assess impact of catheter length and gauge on PIVC indwell time over a 72 hour period. This study will also evaluate the incidence of haemolysis using blood draws from the PIVC.
Study Overview
Status
Intervention / Treatment
Detailed Description
The study aims to provide preliminary information on the performance of the peripheral intravenous catheter (PIVC) device,
- assess how blood collection through different catheters over time effects device performance, and
- assess the quality of the blood that is collected through those catheters. Four variations of the BD Nexiva PIVC will be used in this study. Participants will be randomised by gauge of peripheral intravenous catheter (PIVC) device into the lower arm cephalic vein of both arms. PIVC indwell time will be monitored up to 72 hrs (removal at 72 hrs or upon inability to flush/aspirate). Blood will be collected Day 1 throughout the remainder of indwell time.
Each participant will complete 6 visits: a Screening Visit (V1), PIVC in situ (V2-V5) and follow-up (V6).
The in-situ catheter positions will be compared to the expected tip position based on the catheter lengths. Blood collected will be analysed for haemolysis.
As both device length and gauge are expected to influence haemolysis the study design enables evaluation of both design features.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Queensland
-
Gold Coast, Queensland, Australia, 4111
- Griffith University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female or Male
- 18-65 years of age
- Not pregnant at time of recruitment within 48 hrs Day 1 procedures (self-reported)
- Normal coagulation results (prothrombin time 13-17 sec; activated partial thromboplastin time 27-37 sec)
- Normal platelet aggregation results for ADP, TRAP, and collagen induced maximal amplitude (>70% amplitude over 6 mins)
- Target cephalic veins readily cannulatable (i.e., ≥ ~2.55 mm to obtain C/V ratio less than 45% as indicated by standard 52 of the INS guidelines
- Able and willing to provide verbal and written consent
- Must be an Australian citizen with current Medicare card
Exclusion Criteria:
- History of pro coagulative state/condition (e.g. previous deep vein thrombosis
- Current hypertension (e.g., systolic >139 OR diastolic >89 mmHg)
- Currently on any anti-coagulant or platelet inhibitor medication. Use of NSAIDs and aspirin will be documented however not exclusionary.
- Hemophilia or any current or history of bleeding disorder or tendency
- Presence or report of current blood borne disease/infection (e.g. hepatitis, HIV, leukemia, lymphoma)
- Difficult vascular access (i.e., vein must be readily palpable and cannulatable - no less than ~2.55 mm diameter to maintain ≤45% C/V ratio) as indicated by standard 52 of the INS guidelines
- Allergy or sensitivity to chlorhexidine gluconate, isopropyl alcohol, latex, or skin adhesives
- BMI <18.5 kg/m2 or ≥35 kg/m2
- Positive results for the urine drug screen at screening or check-in (including opiates, methadone, cocaine, amphetamines)
- History or presence of alcoholism (self-reported) or drug abuse within the past 2 years
- A current or previous medical, physical, mental/cognitive disorders or anatomical conditions that, in the opinion of the investigator, would place the patient at risk, would make them unable to perform study procedures or has the potential to confound interpretation of the study results. (e.g., musculo-skeletal injury, chronic back pain)
- Employed by Becton Dickinson, Teleflex Medical, Smiths Medical or B Braun (conflict of interest)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Small gauge arm
2 PIVCs of same gauge and different lengths
|
Randomised controlled
|
OTHER: Large gauge arm
2 PIVCs of same gauge and different lengths
|
Randomised controlled
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess patent indwell time between PIVCs of different length and gauge.
Time Frame: 72 hrs
|
Catheter indwell time for each PIVC
|
72 hrs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To assess haemolysis occurrence based on blood collection device, catheter device configuration
Time Frame: 72 hrs
|
Haemolysis: Frequency of occurrence
|
72 hrs
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BDT-PIVCAU001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Indication for Peripheral Intravenous Catheterisation
-
C. R. BardCompletedIndication for Peripheral Intravenous CatheterizationUnited States
-
Centre Hospitalier Universitaire de Saint EtienneAssociation CNGE IRMGTerminated
-
C. R. BardKJT Group, Inc.CompletedIndication for PICC PlacementUnited States
-
Allina Health SystemCompletedPain | Local Anesthesia for Peripheral Intravenous CatheterizationUnited States
-
GE HealthcareICON plcCompletedClinical Indication for Brain MRIUnited States
-
Cantonal Hosptal, BasellandUnknownIndication for Laparoscopic Surgery (Any)Switzerland
-
Postgraduate Institute of Medical Education and...CompletedPatients With Indication for Flexible BronchoscopyIndia
-
Wissenschaftliches Institut Bethanien e.VCompletedIndication for Invasive Out-of-hospital VentilationGermany
-
Holux Technology, Inc.Shin Kong Wu Ho-Su Memorial HospitalUnknownIndication for Modification of Patient's Cardiopulmonary StatusTaiwan
-
GE HealthcareTerminatedIndication for a PET CT ExamUnited States
Clinical Trials on Peripheral Intravenous Catheter
-
University of IowaCompletedThere is no Focus on Any Specific ConditionUnited States
-
C. R. BardCompletedVascular Access ComplicationUnited States
-
William Beaumont HospitalsWithdrawnPeripheral Intravenous Vein Catheter Phlebitis | Intravenous InfectionUnited States
-
Emory UniversityCompleted
-
The University of Texas Health Science Center,...CompletedContrast Enhanced Computed Tomography (CT) ScanningUnited States
-
Medical College of WisconsinCompletedVascular Access Device ComplicationsUnited States
-
Boston Medical CenterBard Peripheral Vascular, Inc.; Society for Academic Emergency MedicineTerminatedUltrasound Therapy; Complications | Vascular Access ComplicationUnited States
-
Centre Hospitalier Departemental VendeeRecruiting
-
B. Braun Melsungen AGCompletedIntravenous Access According to Instructions For UseGermany
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingCatheter Related ComplicationSpain